Drugs News and Research

RSS

Herring roe oil's potential in psoriasis treatment

Researchers investigated the use of herring row oil to treat psoriasis, a non-communicable skin disease.

12 Sep 2023

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

A new type of vaccine developed by researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis, type 1 diabetes, and Crohn's disease - all without shutting down the rest of the immune system.

12 Sep 2023

Ketogenic dietary intervention may inhibit onset and progression of neuroendocrine tumors

A recent Cell Death and Disease study evaluated the effect of ketogenic dietary intervention on neuroendocrine tumors.

12 Sep 2023

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.

11 Sep 2023

Antidepressants may reduce negative memories, improve memory in depressed individuals

New research from Rice University finds that antidepressants may actually reduce negative memories in individuals suffering from depression while improving overall memory function.

11 Sep 2023

Scientists identify malaria-causing parasites resistant to both treatment and detection in Ethiopia

Scientists have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests - a development that could increase cases and deaths from malaria and make eliminating the persistent disease an even greater challenge.

11 Sep 2023

Low-molecular weight human interleukin-1β antagonist discovered

Researchers described the detection of a human interleukin-1β antagonist with low molecular weight that disrupts interactions with the interleukin-1 receptor type I receptor.

11 Sep 2023

Childhood cancer treatment linked to higher breast cancer risk

Women who have been treated for cancer as a child with a certain type of chemotherapy have an increased risk of breast cancer, according to a large-scale international study of survivors of childhood cancer led by scientists from the Princess Máxima Center for pediatric oncology.

11 Sep 2023

PI3K pathway rewiring drives prostate cancer growth

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators.

11 Sep 2023

Targeted diet and exercise intervention could improve chemotherapy outcomes for breast cancer patients

A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer.

11 Sep 2023

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

10 Sep 2023

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Researchers across Europe have delved into the DNA methylation patterns in CD4+ T-cells of psoriasis and psoriatic arthritis (PsA) patients, unveiling potential new biomarkers for these conditions. Their study suggests that these unique profiles could serve as both diagnostic and prognostic tools, although further validation is needed for real-world clinical application.

10 Sep 2023

Drugs News and Research

Herring roe oil's potential in psoriasis treatment

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

Ketogenic dietary intervention may inhibit onset and progression of neuroendocrine tumors

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antidepressants may reduce negative memories, improve memory in depressed individuals

Scientists identify malaria-causing parasites resistant to both treatment and detection in Ethiopia

Low-molecular weight human interleukin-1β antagonist discovered

Childhood cancer treatment linked to higher breast cancer risk

PI3K pathway rewiring drives prostate cancer growth

Targeted diet and exercise intervention could improve chemotherapy outcomes for breast cancer patients

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Research shines light on early life factors that may increase risk of cardiovascular disease in women

Researchers use machine learning to predict drug approval chances before clinical trials

Research review focuses on the use of psilocybin for treatment of depression

Mount Sinai researchers identify the structure of a special red blood cell transporter

FAU researchers discover novel method to identify therapeutic agents to treat addiction

3D bioprinting methods for fabricating bioengineered blood vessel models

Largest-ever study looks into the genetics of random "round-the-clock" blood glucose levels

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News